NLRP3 and major depressive disorder: We carried out an anti-depression experiment in vivo to identify how TTWC can improve depression-like behavior and alleviate neuronal damage in the hippocampus and prefrontal cortex by regulating the levels of neurotransmitters, the HPA axis, and the NLRP3 signaling pathway.